| Literature DB >> 30047619 |
Chunhai Li1, Bo Liu1, Haipeng Jia1, Zhenyu Dong2, Hong Meng1.
Abstract
BACKGROUND: This retrospectively study was conducted to assess the efficiency and safety of computed tomography (CT)-guided hook wire localization of pulmonary ground-glass nodules (GGNs) prior to video-assisted thoracoscopic surgery (VATS).Entities:
Keywords: Ground-glass nodule; hook wire; localization; video-assisted thoracoscopic surgery
Mesh:
Year: 2018 PMID: 30047619 PMCID: PMC6119612 DOI: 10.1111/1759-7714.12801
Source DB: PubMed Journal: Thorac Cancer ISSN: 1759-7706 Impact factor: 3.500
Figure 1A computed tomography scan shows that the hook wire is positioned in the ground‐glass nodule of a 52‐year old woman.
Patient and nodule characteristics
| Characteristics | Number |
|---|---|
| Male/Female | 37/49 |
| Age (years) | Mean 58.4 (range: 39–75) |
| Smoking history | 38 (44%) |
| Mild‐moderate emphysema | 24 (28%) |
| Tumor history | 12 |
| Nodule size (cm) | Mean 1.4 (range: 0.6–2.2) |
| < 1 | 12 (13.9%) |
| 1–2 | 64 (74.4%) |
| > 2 | 10 (11.6%) |
| Nodule location | |
| RUL | 31 |
| RML | 9 |
| RLL | 13 |
| LUL | 21 |
| LLL | 12 |
| Nodule feature | |
| pGGN | 25 (29%) |
| psGGN | 61 (71%) |
| Nodule distance to pleural surface (mm) | Mean 7.3 (range: 2–19) |
| Nodule distance to hook wire (mm) | |
| Intratumoral | 69 (80.3%) |
| 2–10 mm | 17 (19.7%) |
| Duration of hook wire placement | Mean 19.1 minutes (range: 10–30) |
| Duration of VATS procedure | Mean 49 minutes (range: 28–89) |
| Complication of hook wire | |
| Pneumothorax | 21 (24%) |
| Pulmonary hemorrhage | 18 (21%) |
| Hookwire dislodgement | 1 (1.6%) |
LLL, left lower lobe; LUL, left upper lobe; pGGN, pure ground glass nodule; psGGN, part‐solid GGN; RML, right middle lobe; RUL, right upper lobe; VATS, video‐assisted thoracoscopic surgery.
Figure 2Asymptomatic minor pneumothorax was observed in a 39‐year old woman.
Histopathologic results
| Variables | |
|---|---|
| Malignancy (%) | 77 (89.5%) |
| AAH | 2 |
| AIS | 5 |
| MIA | 19 |
| IA | 46 |
| Metastasis | 5 |
| Benign (%) | 9 (10.5%) |
| Focal inflammation | 7 |
| Fibrosis | 2 |
AAH, atypical adenomatous hyperplasia; AIS, adenocarcinoma in situ; IA, invasive adenocarcinoma; MIA, minimally invasive adenocarcinoma.